YU45246B - Process for preparation of s(-)-3-/3-acethyl-4-(3-terc.buthylamino-2-hydroxypropoxenyl/-1,1-diethyl-urea - Google Patents

Process for preparation of s(-)-3-/3-acethyl-4-(3-terc.buthylamino-2-hydroxypropoxenyl/-1,1-diethyl-urea

Info

Publication number
YU45246B
YU45246B YU443/85A YU44385A YU45246B YU 45246 B YU45246 B YU 45246B YU 443/85 A YU443/85 A YU 443/85A YU 44385 A YU44385 A YU 44385A YU 45246 B YU45246 B YU 45246B
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutically acceptable
diethylurea
acetyl
phenyl
formula
Prior art date
Application number
YU443/85A
Other versions
YU44385A (en
Inventor
G Zoelss
R Gratz
K Schloegl
O Hofer
R J Gordon
Original Assignee
Rorer Int Overseas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer Int Overseas filed Critical Rorer Int Overseas
Publication of YU44385A publication Critical patent/YU44385A/en
Publication of YU45246B publication Critical patent/YU45246B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) S(-)-3-[3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy) phenyl]-1,1-diethylurea (S(-)-celiprolol) and its pharmaceutically acceptable acid addition salts. 1. Claims (for the Contracting State AT) Process for the preparation of S(-)-3-[3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy) phenyl]-1,1-diethylurea (S(-)-celiprolol) and its pharmaceutically acceptable acid addition salts, characterised in that a) the racemate of the formula see diagramm : EP0155518,P10,F1 in the form of the base is reacted with an enantiomer of a chiral resolving acid in a suitable organic solvent, the mixture of the two diastereomeric salts formed in this manner is separated by fractional crystallisation, and, after separating each diastereomeric salt which contains the laevorotatory enantiomer of the compound of the formula I in the S configuration, is reconverted into the free base or a pharmaceutically acceptable addition salt and the resolving acid is recovered, or b) S(+)-3-[3-acetyl-4-(2,3-epoxypropoxy)-phenyl]- 1,1-diethylurea of the formula see diagramm : EP0155518,P10,F2 is reacted with tertiary butylamine in the presence of water at room temperature or with gentle heating to a maximum of 40 degrees C, and then the laevorotatory enantiomer of the compound of the formula I thus obtained is converted as required into a pharmaceutically acceptable addition salt.
YU443/85A 1984-03-21 1985-03-19 Process for preparation of s(-)-3-/3-acethyl-4-(3-terc.buthylamino-2-hydroxypropoxenyl/-1,1-diethyl-urea YU45246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843410380 DE3410380A1 (en) 1984-03-21 1984-03-21 S (-) - CELIPROLOL, THEIR PHARMACEUTICALLY COMPATIBLE SALT, METHOD FOR THE PRODUCTION THEREOF, USE IN THERAPY AND PHARMACEUTICAL PREPARATIONS

Publications (2)

Publication Number Publication Date
YU44385A YU44385A (en) 1987-06-30
YU45246B true YU45246B (en) 1992-05-28

Family

ID=6231193

Family Applications (2)

Application Number Title Priority Date Filing Date
YU44485A YU45707B (en) 1984-03-21 1985-03-19 METHOD FOR PREPARING S (-) - 3- / 3-ACETYL-4- (3-TERC.BUTYLAMINO-2-HYDROXYPROPOXY PHENYL / -1-1-DIETHYL UREA
YU443/85A YU45246B (en) 1984-03-21 1985-03-19 Process for preparation of s(-)-3-/3-acethyl-4-(3-terc.buthylamino-2-hydroxypropoxenyl/-1,1-diethyl-urea

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU44485A YU45707B (en) 1984-03-21 1985-03-19 METHOD FOR PREPARING S (-) - 3- / 3-ACETYL-4- (3-TERC.BUTYLAMINO-2-HYDROXYPROPOXY PHENYL / -1-1-DIETHYL UREA

Country Status (21)

Country Link
EP (1) EP0155518B1 (en)
JP (1) JPS60209557A (en)
AT (1) ATE45945T1 (en)
AU (1) AU567797B2 (en)
CA (1) CA1236116A (en)
CS (2) CS250683B2 (en)
DD (2) DD232489A1 (en)
DE (2) DE3410380A1 (en)
DK (1) DK124585A (en)
ES (1) ES8603390A1 (en)
FI (1) FI83636C (en)
GR (1) GR850496B (en)
HU (1) HU193596B (en)
IL (1) IL74383A (en)
NO (1) NO161254C (en)
PL (2) PL143883B1 (en)
PT (1) PT80135B (en)
RO (2) RO91352B (en)
SU (2) SU1333235A3 (en)
YU (2) YU45707B (en)
ZA (1) ZA852086B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636209A1 (en) * 1986-10-24 1988-04-28 Lentia Gmbh METHOD FOR PRODUCING A BINDER-FREE TABLET-TABLE CELIPROLOL HYDROCHLORIDE GRANULATE
AT388099B (en) * 1986-11-26 1989-04-25 Chemie Holding Ag Process for the production of solid pharmaceutical forms of 3-(3-acetyl-4-(3-tert-butylamino-2- hydroxypropoxy)phenyl)-1,1-diethylurea hydrochloride
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
EP0423484B1 (en) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Tablet with sustained release
DE3935736A1 (en) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressed article for sustained pharmaceutical release - contg. poly-lactic acid and polymer of D-3-hydroxybutyric acid, providing good flow properties and easy compression
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)
CN101239937B (en) * 2007-02-07 2010-05-19 上海雅本化学有限公司 Method for preparing optical activity R-(-)-1-benzylcarbonyl-3-aminopyrrolidine and hydrochloride thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT334385B (en) * 1973-12-20 1976-01-10 Chemie Linz Ag PROCESS FOR THE PREPARATION OF NEW PHENOXYPROPYLAMINE DERIVATIVES AND THEIR SALTS
HU170678B (en) * 1973-12-20 1977-08-28
HU170677B (en) * 1973-12-21 1977-08-28
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma

Also Published As

Publication number Publication date
HU193596B (en) 1987-11-30
YU45707B (en) 1992-07-20
FI850860L (en) 1985-09-22
YU44385A (en) 1987-06-30
DD234860A1 (en) 1986-04-16
ES541424A0 (en) 1985-12-16
DD232489A1 (en) 1986-01-29
NO161254B (en) 1989-04-17
NO161254C (en) 1989-07-26
CS250683B2 (en) 1987-05-14
RO91352B (en) 1987-05-02
DE3410380A1 (en) 1985-10-10
ZA852086B (en) 1985-11-27
SU1309908A3 (en) 1987-05-07
GR850496B (en) 1985-03-15
PT80135B (en) 1987-10-20
RO91352A (en) 1987-04-30
YU44485A (en) 1987-06-30
DE3572656D1 (en) 1989-10-05
ES8603390A1 (en) 1985-12-16
DK124585D0 (en) 1985-03-20
IL74383A (en) 1988-09-30
IL74383A0 (en) 1985-05-31
FI850860A0 (en) 1985-03-04
EP0155518B1 (en) 1989-08-30
NO850834L (en) 1985-09-23
FI83636B (en) 1991-04-30
HUT37392A (en) 1985-12-28
JPS60209557A (en) 1985-10-22
AU3972285A (en) 1985-09-26
AU567797B2 (en) 1987-12-03
PL143883B1 (en) 1988-03-31
DK124585A (en) 1985-09-22
EP0155518A3 (en) 1986-06-25
PL252463A1 (en) 1985-11-19
SU1333235A3 (en) 1987-08-23
RO91353B (en) 1987-05-01
CS250682B2 (en) 1987-05-14
RO91353A (en) 1987-04-30
ATE45945T1 (en) 1989-09-15
EP0155518A2 (en) 1985-09-25
PL252462A1 (en) 1985-11-19
PT80135A (en) 1985-04-01
FI83636C (en) 1991-08-12
CA1236116A (en) 1988-05-03

Similar Documents

Publication Publication Date Title
YU45246B (en) Process for preparation of s(-)-3-/3-acethyl-4-(3-terc.buthylamino-2-hydroxypropoxenyl/-1,1-diethyl-urea
DK166186A (en) METHOD FOR PREPARING QUINOLIN-3-CARBOXYLIC ACID COMPOUNDS
IN167606B (en)
DK339383D0 (en) METHOD FOR PREPARING ALLYLOXY AND ALLYLTHIO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES
FR2385712A1 (en) PROCESS FOR PREPARING CYCLIC ESTERS OF UNDECANEDIOIC ACID
EP0156279A3 (en) A novel process for the preparation of bestatin derivatives and intermediates thereof
JPS5724382A (en) Trithiane derivative and its preparation
JPS5217440A (en) Process for preparation of phenylacetate
DE3169365D1 (en) Indolo-naphthyridines and their use as medicaments
GR81253B (en)
JPS5520743A (en) Alpha-substituted amino-epsilon-caprolactam
JPS56110678A (en) Preparation of alkoxycarbonylmethyl-substituted condensed pyrimidine compound
DE3063221D1 (en) Right-turning basic derivative of 9,10-ethanoanthracene, process for its preparation and pharmaceutical preparations containing it
JPS5663979A (en) Novel vinyl ether derivative and its preparation
RO85262B (en) Process for preparing 3-benzazepines
JPS51143597A (en) Process for purification of impure phosphoric acid
JPS572285A (en) Production of benzoheteroring derivative
JPS5543026A (en) Novel 2-phenyl-1-phthalazone derivative